transplant purifi islet cell diabet rat II immunogen allograft islet beta-cel studi surviv allograft rat islet beta-cel presenc pancreat donor cell graft differ cellular composit streptozocin-induc diabet rat graft diabet state day implant islet variou endocrin nonendocrin cell type wk wk cultur period major chang cellular composit islet surviv allograft islet cell aggreg islet dissoci cell purif infiltr aggreg mhc class ii-neg cell basal normoglycemia recipi wk wk aggreg purifi islet beta-cel free diffus infiltr wk normal state recipi wk wk aglucosur implant insulin reaggreg purifi islet beta-cel purifi islet non-beta-cel long-term surviv allograft recipi mix islet cell normal basal glycemia wk implant constant insulin reserv devoid diffus infiltr result techniqu elimin surfac mhc class ii-posit cell success rat islet allograft low immunogen method posit cell select pure islet beta-cel immunogen allograft milder less-acut immun attack undissoci islet tissu nonendocrin islet cell rapid intens cytotox reaction surviv allograft beta-cel presenc islet endocrin non-beta-cel graft mechan underli effect immun metabol interact endocrin non-beta-cel purif islet endocrin cell new power method insulin-produc allograft host pharmacolog immunosuppress 